ORAVIG

LOE ApproachingSM

miconazole

NDABUCCALTABLET
Approved
Apr 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

12.1 Mechanism of Action Miconazole is an antifungal drug 12.3 Pharmacokinetics Absorption and Distribution Salivary Single dose application of ORAVIG containing 50 mg of miconazole to the buccal mucosa of 18 healthy volunteers provided mean maximum salivary concentrations of 15 mcg/mL at 7 hours…

Pharmacologic Class:

Azole Antifungal

Clinical Trials (3)

NCT01230814Phase 2Completed

Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

Started Apr 2011
NCT01769339Phase 4Completed

An Efficacy and Safety Study of Miconazole and Hydrocortisone Cream in the Treatment of Vulvar Candidiasis

Started Jan 2009
115 enrolled
Vulva; Candidiasis
NCT00702507Phase 4Completed

Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Started May 2007
200 enrolled
Diaper Rash